SA
SCE-PL logo
SCE Trust VI 5% TR PREF SECS(SCE-PL)
Last print unknown agoAbout this dataData status
$14.80▼-0.15 (-1.04%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 31.5 · very high volatility

Overview →

SCE Trust VI 5% TR PREF SECS (SCE-PL)

Common Stock

$6.35B

Quarterly · Period ending: · USD

SCE-PL logo

SCE-PL Common Stock

Latest reported$6.36B
SCE-PL FY Common Stock ($2.69B → $6.36B)
High-resolution chart · PNG

What is common stock?

Par value of issued common shares.

SCE-PL common stock history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

SCE Trust VI 5% TR PREF SECS Common Stock — Annual fiscal periods (USD)
Period endingCommon Stock (USD)
6,362,000,000
6,353,000,000
6,338,000,000
6,200,000,000
6,071,000,000
5,962,000,000
4,990,000,000
2,545,000,000
2,526,000,000
2,505,000,000
2,484,000,000
2,445,000,000
2,403,000,000
2,373,000,000
10,055,000,000
10,583,000,000
2,304,000,000
0
0
0
0
0
0
0
0
0
2,090,000,000
2,109,000,000
2,261,000,000
2,547,000,000
2,660,000,000
2,692,000,000

Frequently asked questions: SCE-PL common stock

What is SCE Trust VI 5% TR PREF SECS (SCE-PL)'s current common stock?

SCE Trust VI 5% TR PREF SECS (SCE-PL)'s latest reported common stock (Quarterly) is $6.35B as of Sep 30, 2026. Par value of issued common shares.

How much historical common stock data is available for SCE-PL?

Stock Alarm Pro provides 32 dated annual fiscal periods observations for SCE Trust VI 5% TR PREF SECS (SCE-PL)'s common stock, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare SCE-PL's common stock to peers or set an alert?

You can open SCE-PL's common stock in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SCE-PL delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.